Tag Archive for: heart failure

gene therapy

Bayer’s Ask Bio unit starts Phase II heart failure gene therapy

Bayer SE subsidiary Asklepios BioPharmaceutical Inc. (AskBio) has started Phase II testing of AB-1002 (NAN-101) in patients with congestive heart failure. 

Read more